Safinamide Impurity 14, identified by its CAS number 878379-14-7, is a chemical compound that is typically associated with the synthesis and quality control of the pharmaceutical drug safinamide, which is used in the treatment of Parkinson's disease. While specific characteristics of this impurity may not be widely documented, impurities in pharmaceuticals generally exhibit properties such as being by-products of the synthesis process, potentially affecting the efficacy and safety of the final product. Impurities like Safinamide Impurity 14 can vary in their chemical structure, stability, and reactivity, and they are often characterized by their molecular weight, solubility, and spectroscopic properties. The presence of such impurities is closely monitored during drug development to ensure compliance with regulatory standards, as they can influence the pharmacological profile and overall quality of the medication. Analytical techniques such as HPLC, NMR, and mass spectrometry are commonly employed to identify and quantify impurities in pharmaceutical formulations.

Safinamide Impurity 14

878379-14-7: Safinamide Impurity 14, identified by its CAS number 878379-14-7, is a chemical compound that is typically associated with the synthesis and quality control of the pharmaceutical drug safinamide, which is used in the treatment of Parkinson's disease. While specific characteristics of this impurity may not be widely documented, impurities in pharmaceuticals generally exhibit properties such as being by-products of the synthesis process, potentially affecting the efficacy and safety of the final product. Impurities like Safinamide Impurity 14 can vary in their chemical structure, stability, and reactivity, and they are often characterized by their molecular weight, solubility, and spectroscopic properties. The presence of such impurities is closely monitored during drug development to ensure compliance with regulatory standards, as they can influence the pharmacological profile and overall quality of the medication. Analytical techniques such as HPLC, NMR, and mass spectrometry are commonly employed to identify and quantify impurities in pharmaceutical formulations.

CAS 878379-14-7

Safinamide Impurity 14

ent-Safinamide Impurity 16

Ref: 4Z-S-073004